Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Changes in Diagnoses and Outcomes for Patients of Hematopathology Specialty and Other Laboratories

Nicole M. Engel-Nitz, Ph.D., Benjamin Eckert, MS, Rui Song, PhD, Erin M. Hulbert, MS, Jeffrey McPheeters, April Teitelbaum, MD, MS, FACP

Blood (2012) 120 (21): 4700.

https://doi.org/10.1182/blood.V120.21.4700.4700

Published: 2012

Journal Articles

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma

Henry J Henk, PhD, Satyin Kaura, MEng, MBA, Zeba M. Khan, PhD, April Teitelbaum

Blood (2012) 120 (21): 4688.

https://doi.org/10.1182/blood.V120.21.4688.4688

Published: 2012

Journal Articles

Investigation of the Association Between Treatment Effects On Progression Free Survival and Overall Survival in Multiple Myeloma Using Data From Published Literature

Bin Zhang, Shannon Cartier, Virginia Rosen, April Teitelbaum, Ying Zhang, Blake J Bartlett, PhD, Glenn Kroog, MD, Pralay Mukhopadhyay, Samuel Wagner, PhD, RPh

Blood (2012) 120 (21): 4241.

https://doi.org/10.1182/blood.V120.21.4241.4241

Published: 2012

Journal Articles

Burden of Illness of Aggressive Systemic Mastocytosis (ASM)

Michelle L Sotak, MPH, MBA, Mihaela Marin, MD, MSc, John Coombs, PharmD, MBA, April Teitelbaum, MD, MS

Blood (2011) 118 (21): 4755.

https://doi.org/10.1182/blood.V118.21.4755.4755

Published: 2011

Journal Articles

Burden of Illness of FLT-3 Mutated Acute Myeloid Leukemia (AML)

Michelle L Sotak, MPH, MBA, Mihaela Marin, MD, MSc, John Coombs, PharmD, MBA, Gary J. Schiller, MD, April Teitelbaum, MD, MS

Blood (2011) 118 (21): 4765.

https://doi.org/10.1182/blood.V118.21.4765.4765

Published: 2011

Journal Articles

Multiple Myeloma: Patient out-of-Pocket Costs and Health Care Utilization.

Brett Pinsky, Hui Huang, April Teitelbaum, Dixie-Lee Esseltine, Henry J Henk

Blood (2009) 114 (22): 1366.

https://doi.org/10.1182/blood.V114.22.1366.1366

Published: 2009

NARROW

Changes in Diagnoses and Outcomes for Patients of Hematopathology Specialty and Other Laboratories

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma

Investigation of the Association Between Treatment Effects On Progression Free Survival and Overall Survival in Multiple Myeloma Using Data From Published Literature

Burden of Illness of Aggressive Systemic Mastocytosis (ASM)

Burden of Illness of FLT-3 Mutated Acute Myeloid Leukemia (AML)

Multiple Myeloma: Patient out-of-Pocket Costs and Health Care Utilization.

Email alerts

ASH Publications

American Society of Hematology

Changes in Diagnoses and Outcomes for Patients of Hematopathology Specialty and Other Laboratories

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma

Investigation of the Association Between Treatment Effects On Progression Free Survival and Overall Survival in Multiple Myeloma Using Data From Published Literature

Burden of Illness of Aggressive Systemic Mastocytosis (ASM)

Burden of Illness of FLT-3 Mutated Acute Myeloid Leukemia (AML)

Multiple Myeloma: Patient out-of-Pocket Costs and Health Care Utilization.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only